Generic Name and Formulations:
Lodoxamide tromethamine 0.1%; oph soln; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for ALOMIDE:
Vernal conjunctivitis, keratoconjunctivitis, or keratitis.
Adults and Children:
<2yrs: not recommended. ≥2yrs: 1–2 drops 4 times daily for up to 3 months.
Do not wear soft contact lenses during treatment.
Pregnancy (Cat.B). Nursing mothers.
Mast cell stabilizer.
Transient burning, stinging or discomfort, pruritus, blurred vision, dry eye, discharge, hyperemia, crystalline deposits, foreign body sensation, headache.
Psychiatry Advisor Articles
- ADHD, Comorbid Bipolar Disorder Share Similar Neurocognitive Profiles
- Anxiety Prevention Interventions: How Effective Are They?
- ACOG Update: Marijuana Use Discouraged During Pregnancy, Breastfeeding
- Depression Profiles in Patients With Type 1 Diabetes vs Type 2 Diabetes
- No Evidence of Personality Changes Prior to Developing Cognitive Impairment, Dementia
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- Physicians Spend Nearly 6 Hours on EHR Tasks Per Day
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Is Hypertension Linked to an Increased Risk of Dementia?
- Continuing Research, Emerging Treatments Hold Promise for Treating Anorexia Nervosa
- Maternal Glucocorticoid Exposure Not Associated With ADHD in Offspring
- Ketamine Not Associated With PTSD Development in Military Trauma Setting
- Content, Quality Issues for Both Paper-Based and Electronic Health Records